MindBio Therapeutics (XCNQ:MBIO) Total Liabilities : C$5.27 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Total Liabilities?

MindBio Therapeutics's Total Liabilities for the quarter that ended in Mar. 2024 was C$5.27 Mil.

MindBio Therapeutics's quarterly Total Liabilities increased from Sep. 2023 (C$5.17 Mil) to Dec. 2023 (C$5.26 Mil) and increased from Dec. 2023 (C$5.26 Mil) to Mar. 2024 (C$5.27 Mil).

MindBio Therapeutics's annual Total Liabilities increased from Jun. 2021 (C$0.89 Mil) to Jun. 2022 (C$5.26 Mil) and increased from Jun. 2022 (C$5.26 Mil) to Jun. 2023 (C$5.43 Mil).

MindBio Therapeutics Total Liabilities Historical Data

The historical data trend for MindBio Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Total Liabilities Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Total Liabilities

0.89

5.26

5.43

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial					4.69	5.43	5.17	5.26	5.27

MindBio Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MindBio Therapeutics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.609	+	(2.512	+	0.312
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.43

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	0.6	-	-4.833
	=	5.43

MindBio Therapeutics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.417	+	(3.545	+	0.31
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.27

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	0.277	-	-4.995
	=	5.27

MindBio Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.